Table 3.

Median survival after recurrence

	Number of events	Median survival,*years (IQR)	Hazard ratio (95% CI)	Log-rank p value†
Vaginal or pelvic recurrence
Chemoradiotherapy	4	1·2 (0·7–NR)	··	··
Radiotherapy alone	6	1·4 (0·9–NR)	··	··
Total	10	1·4 (0·9–NR)	1·31 (0·26–6·55)	0·74
Distant metastases
Chemoradiotherapy	76	1·2 (0·3–8·9)	··	··
Radiotherapy alone	93	1·5 (0·7–3·7)	··	··
Total	169	1·4 (0·5–3·7)	1·05 (0·73–1·50)	0·79
Any recurrence
Chemoradiotherapy	82	1·2 (0·4–8·9)	··	··
Radiotherapy alone	103	1·4 (0·7–3·7)	··	··
Total	185	1·4 (0·5–3·7)	1·06 (0·75–1·51)	0·72

NR=not reached.

^*For median survival after recurrence, the first site of recurrence was used.

^†Unadjusted for stratification factors.